Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 May;19(S2):S16-S26.
doi: 10.1089/dia.2017.0029.

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters

Lorena Alarcon-Casas Wright  1 , Irl B Hirsch  1
Affiliations
Review

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters

Lorena Alarcon-Casas Wright et al. Diabetes Technol Ther. 2017 May.

Abstract

We review clinical instances in which A1C should not be used and reflect on the use of other glucose metrics that can be used, in substitution of or in combination with A1C and SMBG, to tailor an individualized approach that will result in better outcomes and patient empowerment.

Keywords: Continuous glucose monitoring; Flash-continuous glucose monitoring; Glucose metrics; Glycemic biomarkers.

PubMed Disclaimer

Conflict of interest statement

Dr. Lorena Alarcon-Casas Wright has no conflicts of interest. Dr. Irl B. Hirsch is a consultant for Abbott Diabetes Care, Intarcia, Roche, and Valeritas.

Figures

<b>FIG. 1.</b>
FIG. 1.
FCGM in a 60-year-old African American woman with a falsely elevated A1C of 8.1%.
See this image and copyright information in PMC

References

    1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977–986 - PubMed
    1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:837–853 - PubMed
    1. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998;352:854–865 - PubMed
    1. Standards of Medical Care in Diabetes-2017: Summary of revisions. Diabetes Care 2017;40(Suppl 1):S4–S5 - PubMed
    1. Sacks DB: Hemoglobin A1c in diabetes: panacea or pointless? Diabetes 2013;62:41–43 - PMC - PubMed

Substances